- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股处于空头行情中，可能有短期反弹。
- 中期趋势：
回落整理中且下跌有加速趋势。
- 长期趋势：
已有298家主力机构披露2025-12-31报告期持股数据，持仓量总计1.78亿股，占流通A股11.86%
- 波段诊断：
-
技术面诊股
诊断结果：3.3技术面打败了31%的股票
技术面评分前10的股票
近期的平均成本为15.10元。多头行情中，目前处于回落整理阶段且下跌有加速趋势。
平均成本
近期的平均成本为15.10元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"15.10","date":1780474619,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2026.06.04","stock":"-2.02","trade":"-1.80","ind":"-0.64"},{"date":"2026.06.03","stock":"-2.29","trade":"-1.10","ind":"0.22"},{"date":"2026.06.02","stock":"-2.24","trade":"-2.06","ind":"0.43"},{"date":"2026.06.01","stock":"0.69","trade":"0.40","ind":"-0.27"},{"date":"2026.05.29","stock":"-0.75","trade":"0.36","ind":"-0.73"},{"date":"2026.05.28","stock":"1.58","trade":"-0.71","ind":"0.12"},{"date":"2026.05.27","stock":"-1.62","trade":"-1.05","ind":"-1.25"},{"date":"2026.05.26","stock":"1.90","trade":"-1.43","ind":"-0.17"},{"date":"2026.05.25","stock":"-3.84","trade":"-1.35","ind":"0.96"},{"date":"2026.05.22","stock":"-3.53","trade":"0.11","ind":"0.87"},{"date":"2026.05.21","stock":"2.22","trade":"-1.67","ind":"-2.04"},{"date":"2026.05.20","stock":"1.52","trade":"-0.92","ind":"-0.18"},{"date":"2026.05.19","stock":"1.36","trade":"0.64","ind":"0.92"},{"date":"2026.05.18","stock":"-2.06","trade":"-1.49","ind":"-0.09"},{"date":"2026.05.15","stock":"-0.30","trade":"-0.71","ind":"-1.02"},{"date":"2026.05.14","stock":"-2.24","trade":"-1.71","ind":"-1.52"},{"date":"2026.05.13","stock":"-0.82","trade":"-0.44","ind":"0.67"},{"date":"2026.05.12","stock":"-2.12","trade":"-1.41","ind":"-0.25"},{"date":"2026.05.11","stock":"6.14","trade":"1.65","ind":"1.08"},{"date":"2026.05.08","stock":"0.43","trade":"0.14","ind":"-0.00"},{"date":"2026.05.07","stock":"1.74","trade":"-0.07","ind":"0.48"}]
华海药业,上证指数,化学制药指数
压力支撑
该股压力位为15.14元，支撑位为14.78元。
[{"text":"\u538b\u529b\u4f4d","value":"15.14","date":1780502400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.78","date":1780502400,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌有加速趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.4资金面打败了10%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：06月04日 20:31
| 机构今日流向(万元) | -1117.32 | 机构5日流向(万元) | -3445.70 |
| 机构10日流向(万元) | -10567.58 | 机构20日流向(万元) | -27728.09 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少9264.78万股，其中基金净减仓32家，主力净减仓139家，请投资者中长期谨慎为宜。
截止2025-12-31，共298家主力机构（基金293家，一般法人4家，社保基金1家），持仓量总计17756.4万股，占流通A股11.86%
其中，基金持仓与2025-06-30相比：
增仓：71家 ，增持 2426.95万股
减仓：103家 ，减持 3748.39万股
新出现在主力名单中：107家 ，持有3414.54万股
从主力名单中消失：246家 ，原持有11157.61万股
其中，基金持仓与2025-06-30相比：
增仓：71家 ，增持 2426.95万股
减仓：103家 ，减持 3748.39万股
新出现在主力名单中：107家 ，持有3414.54万股
从主力名单中消失：246家 ，原持有11157.61万股
消息面诊股
诊断结果：5.7消息面打败了49%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 华海药业：6月3日获融资买入2739.97万元
2026-06-04 - 华海药业：目前公司正积极与相关方沟通，加快推进审评
2026-06-03 - 抗抑郁药“一哥”易主！TOP20洗牌，独家品种暴涨
2026-06-03 - 华海药业：HB0034注射液注册上市许可申请已获得
2026-06-03 - 华海药业：公司已在创新药研发阶段中应用AI技术
2026-06-03 - 华海药业：HB0025的III期临床研究正在进行受
2026-06-03 - 华海药业HB0056注射液获批IPF适应症临床试验
2026-06-03 - 华海药业：6月2日获融资买入2130.39万元
2026-06-03 - 华海药业：子公司HB0056获特发性肺纤维化临床试
2026-06-02 - 【火热】华海药业1541万喜提2大新品，拿下涨逾1
2026-06-02
消息列表
| 一般消息 | 募资投向 | 2026-06-01 | |
| 一般消息 | 高管变动 | 因个人原因 | 2026-05-21 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-05-12 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-30 |
| 利好 | 分红转增 | 10派1.0元(含税) | 2026-04-30 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-04-30 |
| 利好 | 业绩预告 | 业绩预增 | 2026-04-15 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-03-21 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2026-01-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-27 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 1条 | 1条 | 0条 |
行业面诊股
诊断结果：4.8行业面打败了72%的股票
化学制药行业最新资金流向
近10日来该行业走势总体向下，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，明显跑输大盘。
[{"date":"2026.06.04","price":"-0.64","value":"-1.80"},{"date":"2026.06.03","price":"0.22","value":"-1.10"},{"date":"2026.06.02","price":"0.43","value":"-2.06"},{"date":"2026.06.01","price":"-0.27","value":"0.40"},{"date":"2026.05.29","price":"-0.73","value":"0.36"},{"date":"2026.05.28","price":"0.12","value":"-0.71"},{"date":"2026.05.27","price":"-1.25","value":"-1.05"},{"date":"2026.05.26","price":"-0.17","value":"-1.43"},{"date":"2026.05.25","price":"0.96","value":"-1.35"},{"date":"2026.05.22","price":"0.87","value":"0.11"},{"date":"2026.05.21","price":"-2.04","value":"-1.67"},{"date":"2026.05.20","price":"-0.18","value":"-0.92"},{"date":"2026.05.19","price":"0.92","value":"0.64"},{"date":"2026.05.18","price":"-0.09","value":"-1.49"},{"date":"2026.05.15","price":"-1.02","value":"-0.71"},{"date":"2026.05.14","price":"-1.52","value":"-1.71"},{"date":"2026.05.13","price":"0.67","value":"-0.44"},{"date":"2026.05.12","price":"-0.25","value":"-1.41"},{"date":"2026.05.11","price":"1.08","value":"1.65"},{"date":"2026.05.08","price":"-0.00","value":"0.14"},{"date":"2026.05.07","price":"0.48","value":"-0.07"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 纳微科技 | 22.25% | 2.41% | 5.7分 |
| 2 | 科源制药 | 14.51% | 11.43% | 5.9分 |
| 3 | 东亚药业 | 14.32% | 8.61% | 5.9分 |
| 4 | 翰宇药业 | 8.96% | -6.12% | 5.5分 |
| 5 | 昂利康 | 7.51% | -0.82% | 4.5分 |
| 6 | ST景峰 | 1.42% | -0.56% | 4.7分 |
| 8 | 新和成 | -2.45% | 2.10% | 5.1分 |
| 10 | 国邦医药 | -3.35% | 4.76% | 6.0分 |
| 12 | 仙琚制药 | -3.95% | 0.24% | 4.8分 |
| 14 | ST诺泰 | -4.17% | -3.33% | 4.4分 |
| 16 | ST能特 | -5.44% | 2.26% | 4.1分 |
| 18 | 国药现代 | -6.04% | 0.23% | 4.7分 |
| 20 | 华特达因 | -6.21% | 1.12% | 4.6分 |
| 22 | 海翔药业 | -6.69% | 5.73% | 5.3分 |
| 24 | 华润双鹤 | -7.14% | 0.91% | 4.6分 |
| 26 | 华邦健康 | -7.85% | -0.67% | 4.5分 |
| 28 | 华海药业 | -8.18% | -6.47% | 4.4分 |
| 30 | 一品红 | -8.52% | -4.09% | 4.8分 |
| 32 | 灵康药业 | -8.54% | -2.40% | 5.0分 |
| 34 | 九典制药 | -8.89% | -2.34% | 4.4分 |
| 36 | 贝达药业 | -9.21% | -1.21% | 5.0分 |
| 38 | 天新药业 | -10.02% | -3.47% | 4.9分 |
| 40 | 恩华药业 | -10.30% | -3.43% | 4.4分 |
| 42 | 诚意药业 | -10.72% | -5.41% | 4.5分 |
| 44 | 溢多利 | -10.95% | -6.93% | 4.3分 |
| 46 | 中关村 | -11.18% | -3.73% | 4.7分 |
| 48 | 复星医药 | -11.77% | -4.09% | 4.1分 |
| 50 | 天宇股份 | -12.01% | -5.29% | 5.0分 |
| 52 | - | -12.19% | -2.43% | 分 |
| 54 | 鲁抗医药 | -12.43% | -5.91% | 4.0分 |
| 56 | 海普瑞 | -12.66% | -2.88% | 5.3分 |
| 58 | 圣诺生物 | -12.79% | -5.22% | 4.6分 |
| 60 | 健友股份 | -12.86% | -0.63% | 5.1分 |
| 62 | 艾力斯 | -13.02% | -4.74% | 5.0分 |
| 64 | 哈药股份 | -13.39% | -3.06% | 4.4分 |
| 66 | 力生制药 | -13.50% | -2.11% | 4.9分 |
| 68 | 泽璟制药 | -13.93% | -7.09% | 4.7分 |
| 70 | - | -13.94% | -2.45% | 分 |
| 72 | - | -13.99% | -3.81% | 分 |
| 74 | 千红制药 | -14.08% | -2.61% | 4.9分 |
| 76 | 辰欣药业 | -14.24% | -1.77% | 4.3分 |
| 78 | - | -14.34% | -3.09% | 分 |
| 80 | 舒泰神 | -14.41% | 3.98% | 3.6分 |
| 82 | ST复华 | -14.68% | -5.65% | 3.5分 |
| 84 | 川宁生物 | -14.73% | -4.38% | 3.8分 |
| 86 | 吉贝尔 | -14.81% | -3.59% | 4.3分 |
| 88 | 浙江医药 | -14.99% | -3.97% | 4.3分 |
| 90 | 卫信康 | -15.11% | -3.69% | 4.5分 |
| 92 | 双鹭药业 | -15.15% | -3.61% | 4.3分 |
| 94 | 亨迪药业 | -15.31% | -4.25% | 4.2分 |
| 96 | 民生健康 | -15.61% | -3.12% | 4.4分 |
| 98 | 前沿生物 | -15.88% | -8.56% | 4.8分 |
| 100 | 誉衡药业 | -15.93% | -3.72% | 4.9分 |
| 102 | 宣泰医药 | -16.03% | -7.66% | 4.4分 |
| 104 | 亚太药业 | -16.07% | -4.41% | 3.8分 |
| 106 | 康芝药业 | -16.27% | -3.63% | 3.9分 |
| 108 | 立方制药 | -16.61% | -2.23% | 5.2分 |
| 110 | 海正药业 | -16.70% | -4.54% | 4.2分 |
| 112 | 凯因科技 | -17.11% | -3.94% | 4.2分 |
| 114 | 新天地 | -17.31% | -6.02% | 4.1分 |
| 116 | 本立科技 | -17.63% | -7.37% | 4.7分 |
| 118 | 莱美药业 | -17.83% | -7.53% | 4.2分 |
| 120 | - | -17.99% | -3.41% | 分 |
| 122 | 奥锐特 | -18.32% | -3.77% | 5.3分 |
| 124 | - | -18.57% | -5.03% | 分 |
| 126 | 金石亚药 | -18.92% | -6.13% | 4.3分 |
| 128 | 三圣股份 | -19.12% | -4.02% | 3.9分 |
| 130 | 汇宇制药 | -19.35% | -9.17% | 4.5分 |
| 132 | 益方生物 | -19.55% | -6.35% | 4.2分 |
| 134 | 赛托生物 | -19.67% | -5.53% | 4.3分 |
| 136 | 首药控股 | -20.22% | -9.68% | 4.0分 |
| 138 | 新诺威 | -21.17% | -2.76% | 4.2分 |
| 140 | 兴齐眼药 | -22.18% | -7.02% | 4.3分 |
| 142 | 润都股份 | -22.48% | -6.09% | 4.5分 |
| 144 | 亚虹医药 | -22.86% | -10.94% | 3.9分 |
| 146 | 悦康药业 | -23.15% | -9.39% | 4.9分 |
| 148 | 罗欣药业 | -23.86% | -2.11% | 5.1分 |
| 150 | 海辰药业 | -24.58% | -6.45% | 4.3分 |
| 152 | 苑东生物 | -24.98% | -8.06% | 4.4分 |
| 154 | 迪哲医药 | -28.62% | -25.12% | 4.6分 |
| 156 | 博瑞医药 | -30.46% | -9.92% | 4.4分 |
| 158 | 仟源医药 | -32.00% | -15.22% | 4.3分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 16/218 ， 62/218。
[{"date":"2026-03-31","value":"4.19","vol":"0.43"},{"date":"2025-12-31","value":"2.90","vol":"-2.03"},{"date":"2025-09-30","value":"4.13","vol":"1.53"},{"date":"2025-06-30","value":"4.35","vol":"1.24"},{"date":"2025-03-31","value":"3.18","vol":"-0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
4.19 | 2.90 | 4.13 | 4.35 | 3.18 |
| 行业(%) | 0.43 | -2.03 | 1.53 | 1.24 | -0.13 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"57.67","vol":"50.72"},{"date":"2025-12-31","value":"60.16","vol":"49.72"},{"date":"2025-09-30","value":"61.71","vol":"49.60"},{"date":"2025-06-30","value":"63.32","vol":"49.57"},{"date":"2025-03-31","value":"64.78","vol":"49.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
57.67 | 60.16 | 61.71 | 63.32 | 64.78 |
| 行业(%) | 50.72 | 49.72 | 49.60 | 49.57 | 49.06 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 85/218 ， 44/218。
[{"date":"2026-03-31","value":"-1.40","vol":"25.51"},{"date":"2025-12-31","value":"-10.06","vol":"38.97"},{"date":"2025-09-30","value":"-11.57","vol":"141.63"},{"date":"2025-06-30","value":"-11.93","vol":"78.56"},{"date":"2025-03-31","value":"-5.21","vol":"0.01"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-1.40 | -10.06 | -11.57 | -11.93 | -5.21 |
| 行业(%) | 25.51 | 38.97 | 141.63 | 78.56 | 0.01 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"35.90","vol":"47.13"},{"date":"2025-12-31","value":"-76.19","vol":"-26.11"},{"date":"2025-09-30","value":"-63.12","vol":"-2.93"},{"date":"2025-06-30","value":"-45.30","vol":"59.61"},{"date":"2025-03-31","value":"9.81","vol":"-10.40"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
35.90 | -76.19 | -63.12 | -45.30 | 9.81 |
| 行业(%) | 47.13 | -26.11 | -2.93 | 59.61 | -10.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 57/218 ， 125/218。
[{"date":"2026-03-31","value":"0.11","vol":"0.10"},{"date":"2025-12-31","value":"0.41","vol":"0.41"},{"date":"2025-09-30","value":"0.31","vol":"0.31"},{"date":"2025-06-30","value":"0.22","vol":"0.21"},{"date":"2025-03-31","value":"0.11","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.11 | 0.41 | 0.31 | 0.22 | 0.11 |
| 行业(次) | 0.10 | 0.41 | 0.31 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.27","vol":"0.65"},{"date":"2025-12-31","value":"0.96","vol":"2.58"},{"date":"2025-09-30","value":"0.68","vol":"1.93"},{"date":"2025-06-30","value":"0.47","vol":"1.29"},{"date":"2025-03-31","value":"0.24","vol":"0.66"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.27 | 0.96 | 0.68 | 0.47 | 0.24 |
| 行业(次) | 0.65 | 2.58 | 1.93 | 1.29 | 0.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"17.07","vol":"-2.81"},{"date":"2025-12-31","value":"26.52","vol":"16.49"},{"date":"2025-09-30","value":"14.94","vol":"4.26"},{"date":"2025-06-30","value":"8.13","vol":"2.95"},{"date":"2025-03-31","value":"8.24","vol":"-26.33"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 17.07 | 26.52 | 14.94 | 8.13 | 8.24 |
| 行业 | -2.81 | 16.49 | 4.26 | 2.95 | -26.33 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.92","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.55","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.92 | - | 1.55 | - |
| 行业 | 0.00 | 1.60 | 0.00 | 1.71 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 73/218 ， 44/218。
[{"date":"2026-03-31","value":"1.01","vol":"3.57"},{"date":"2025-12-31","value":"0.96","vol":"3.31"},{"date":"2025-09-30","value":"1.32","vol":"3.48"},{"date":"2025-06-30","value":"1.56","vol":"3.66"},{"date":"2025-03-31","value":"1.62","vol":"3.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.01 | 0.96 | 1.32 | 1.56 | 1.62 |
| 行业 | 3.57 | 3.31 | 3.48 | 3.66 | 3.57 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.59","vol":"2.93"},{"date":"2025-12-31","value":"0.53","vol":"2.69"},{"date":"2025-09-30","value":"0.70","vol":"2.73"},{"date":"2025-06-30","value":"0.89","vol":"2.88"},{"date":"2025-03-31","value":"0.99","vol":"2.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
0.59 | 0.53 | 0.70 | 0.89 | 0.99 |
| 行业 | 2.93 | 2.69 | 2.73 | 2.88 | 2.80 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 21/218 ， 26/218。
[{"date":"2026-03-31","value":"55.64","vol":"33.54"},{"date":"2025-12-31","value":"56.02","vol":"34.70"},{"date":"2025-09-30","value":"54.62","vol":"34.06"},{"date":"2025-06-30","value":"52.95","vol":"34.12"},{"date":"2025-03-31","value":"53.94","vol":"34.09"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
55.64 | 56.02 | 54.62 | 52.95 | 53.94 |
| 行业(%) | 33.54 | 34.70 | 34.06 | 34.12 | 34.09 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.26","vol":"9.77"},{"date":"2025-12-31","value":"1.28","vol":"1.76"},{"date":"2025-09-30","value":"1.21","vol":"1.19"},{"date":"2025-06-30","value":"1.14","vol":"0.87"},{"date":"2025-03-31","value":"1.19","vol":"1.44"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.26 | 1.28 | 1.21 | 1.14 | 1.19 |
| 行业(%) | 9.77 | 1.76 | 1.19 | 0.87 | 1.44 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 长江证券 | 2026-05-26 | 买入 | |
| 招商证券 | 2026-05-07 | 买入 | |
| 华创证券 | 2026-03-31 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"11.68","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"8.30","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"11.19","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"2.66","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"7.52","blueLineValue":"0.50","type":"YC"}]